Recombinant Poliovirus Receptor 抗体
Our Local Distributor
北京 101111
Quick Overview for Recombinant Poliovirus Receptor 抗体 (ABIN7610010)
抗原
See all Poliovirus Receptor (PVR) 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
Expression System
- HEK-293F Cells
-
原理
- Pvr Recombinant Antibody
-
产品特性
- The Pvr Recombinant Antibody (Species: Human) has been validated for the following applications: ELISA, WB, IHC.
-
纯化方法
- Affinity-Chromatography
-
免疫原
- A Synthesized Peptide Derived From Human Pvr
-
亚型
- IgG
-
-
anti-Poliovirus Receptor (PVR) (AA 21-343) antibody
PVR 适用: 人 ELISA, FACS 宿主: 小鼠 Monoclonal 6D2D6 unconjugated
anti-Poliovirus Receptor (PVR) (AA 22-255) antibodyPVR 适用: 大鼠 WB, IHC, ICC, IP 宿主: 兔 Polyclonal unconjugated
anti-Poliovirus Receptor (PVR) antibodyPVR 适用: 小鼠 ELISA, FACS 宿主: 兔 Chimeric 3F1 unconjugated Recombinant Antibody
anti-Poliovirus Receptor (PVR) (AA 1-417) antibodyPVR 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Poliovirus Receptor (PVR) (AA 56-309) antibodyPVR 适用: 人 WB, IHC, ICC, IP 宿主: 兔 Polyclonal unconjugated
anti-Poliovirus Receptor (PVR) (AA 220-345) antibodyPVR 适用: 人 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Poliovirus Receptor (PVR) antibodyKD Validated PVR 适用: 人 WB 宿主: 兔 Monoclonal 23GB2575 unconjugated Recombinant Antibody
anti-Poliovirus Receptor (PVR) (Internal Region) antibodyPVR 适用: 人, 小鼠, 大鼠 WB, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Poliovirus Receptor (PVR) (AA 21-343) antibodyPVR 适用: 人 ELISA, FACS 宿主: 兔 Monoclonal DM146 unconjugated
anti-Poliovirus Receptor (PVR) (AA 220-345) antibodyPVR 适用: 人 WB, IF 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- Lot specific
-
缓冲液
- Rabbit IgG in Phosphate Buffered Saline, pH 7.4, 150 mM NaCl, 0.02 % Sodium Azide and 50 % Glycerol
-
储存条件
- 4 °C,-20 °C
-
储存方法
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
有效期
- 12 months
-
-
- Poliovirus Receptor (PVR)
-
别名
- PVR
-
UniProt
- P15151
-
途径
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Cancer Immune Checkpoints, SARS-CoV-2 Protein Interactome
抗原
-
